Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study

Abstract Introduction In the DELIVER study, eptinezumab reduced monthly migraine days (MMDs) more than placebo in patients with 2–4 prior preventive migraine treatment failures. This post hoc analysis evaluated the efficacy of eptinezumab across the 24-week placebo-controlled period of the DELIVER s...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Patricia Pozo-Rosich, Messoud Ashina, Stewart J. Tepper, Sidsel Jensen, Line Pickering Boserup, Mette Krog Josiassen, Bjørn Sperling
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2024-01-01
coleção:	Neurology and Therapy
Assuntos:	Anti-CGRP Eptinezumab Migraine Preventive treatment
Acesso em linha:	https://doi.org/10.1007/s40120-023-00575-5
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!